Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

KAPA

Kairos Pharma, LTD.

CIK 0001962011 · NYSE American

NYSE AmericanHealth CarePharmaceutical Preparations
$0.29
↓ 0.01 (-1.73%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$6.21M
P/E Ratio
-1.07
EPS
-0.30
Dividend Yield
Not covered
52W Position
1%
Beta
1.67

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.48
P/S
Not covered
EV/Revenue
Not covered
ROE
-138.5%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 1%
$0.27$2.11

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$5.45M
Total Assets
$6.54M
Free Cash Flow
–

Recent news